JPH0464703B2 - - Google Patents
Info
- Publication number
- JPH0464703B2 JPH0464703B2 JP59137225A JP13722584A JPH0464703B2 JP H0464703 B2 JPH0464703 B2 JP H0464703B2 JP 59137225 A JP59137225 A JP 59137225A JP 13722584 A JP13722584 A JP 13722584A JP H0464703 B2 JPH0464703 B2 JP H0464703B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- plasma
- depressions
- mixture
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 11
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims description 9
- 108010010803 Gelatin Proteins 0.000 claims description 9
- 229960002684 aminocaproic acid Drugs 0.000 claims description 9
- 229920000159 gelatin Polymers 0.000 claims description 9
- 239000008273 gelatin Substances 0.000 claims description 9
- 235000019322 gelatine Nutrition 0.000 claims description 9
- 235000011852 gelatine desserts Nutrition 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 230000037311 normal skin Effects 0.000 claims description 2
- -1 plasma Substances 0.000 claims 2
- 239000011344 liquid material Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 description 9
- 102000009123 Fibrin Human genes 0.000 description 6
- 108010073385 Fibrin Proteins 0.000 description 6
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 6
- 229950003499 fibrin Drugs 0.000 description 6
- 231100000241 scar Toxicity 0.000 description 6
- 208000032544 Cicatrix Diseases 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 230000037387 scars Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 description 2
- 201000006082 Chickenpox Diseases 0.000 description 2
- 208000009889 Herpes Simplex Diseases 0.000 description 2
- 208000007514 Herpes zoster Diseases 0.000 description 2
- 206010046980 Varicella Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000012931 lyophilized formulation Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59137225A JPS6120549A (ja) | 1984-07-04 | 1984-07-04 | 皮膚陥凹修復のための組成物と、それを使用する皮膚陥凹修復方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59137225A JPS6120549A (ja) | 1984-07-04 | 1984-07-04 | 皮膚陥凹修復のための組成物と、それを使用する皮膚陥凹修復方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6120549A JPS6120549A (ja) | 1986-01-29 |
| JPH0464703B2 true JPH0464703B2 (pl) | 1992-10-15 |
Family
ID=15193700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59137225A Granted JPS6120549A (ja) | 1984-07-04 | 1984-07-04 | 皮膚陥凹修復のための組成物と、それを使用する皮膚陥凹修復方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6120549A (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4210231B2 (ja) * | 2004-03-25 | 2009-01-14 | 株式会社資生堂 | 皮膚のシワを改善する美容方法及びシワ改善具 |
| DE102005054937A1 (de) * | 2005-11-17 | 2007-05-24 | Gelita Ag | Angiogenese förderndes Substrat |
-
1984
- 1984-07-04 JP JP59137225A patent/JPS6120549A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6120549A (ja) | 1986-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5037810A (en) | Medical application for heparin and related molecules | |
| US4061731A (en) | Compositions containing collagen and methods of use for repairing depressed cutaneous scars | |
| Warrell et al. | Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria | |
| Yaffe et al. | Restoration of periodontal attachment employing enriched collagen solution in the dog | |
| CA1315683C (en) | Medical application for heparin and related molecules | |
| KR100795654B1 (ko) | 당뇨성 발 절단 예방을 위한 표피성장인자 함유 약제학적조성물의 용도 | |
| JPH0813742B2 (ja) | 血液凝固阻止剤 | |
| JP3012319B2 (ja) | 脳及び筋肉組織傷害による浮腫の治療剤 | |
| US4302577A (en) | Process for preparing CSA or CSC | |
| Jamision et al. | LYSIS OF A SUPERIOR MESENTERIC ARTERY EMBOUS FOLLOWING LOCAL INFUSION OF STREPTOKINASE AND HEPARIN | |
| JPH06503319A (ja) | 細胞増殖マトリックス及びその用法 | |
| Fisher et al. | Partial rupture of the tendo calcaneus with heterotopic ossification: report of a case | |
| JP3480737B2 (ja) | 瘢痕組織の処置のための方法 | |
| JPH0464703B2 (pl) | ||
| WESSLER et al. | Theory and practice in acute venous thrombosis: a reappraisal | |
| Schneider | Hyaluronidase with local anesthesia in anorectal surgery | |
| Elkeles et al. | ABC of vascular diseases. The diabetic foot. | |
| Santos-Dias | CO2 laser surgery in hemophilia treatment | |
| MORANI | Trypsin therapy in the management of chronic surface ulcers | |
| Winstock et al. | Dental extractions in haemophilia: plasma therapy without dental splints | |
| SMITH | Amputation through lower third of leg for diabetic and arteriosclerotic gangrene | |
| LEWIS et al. | The Use of Plasma Fraction I to Maintain Hemostasis Following Amputation for Hemorrhagic Cyst of the Thigh in a Severe Hemophiliac | |
| Pohle et al. | The use of a globulin substance derived from beef plasma as a local hemostatic in hemophilia | |
| RU2093093C1 (ru) | Способ лечения глубоких отморожений пальцев кисти | |
| Miles et al. | Major surgical procedures, including amputation, on a hemophiliac |